Name: SRTA Income Statement - Strata Critical Medical Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SRTA - Strata Critical Medical, Inc.

USD | NASDAQ | Healthcare

SRTA Income Statement - Strata Critical Medical Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q3 FY 19
Revenues
Revenues	67.4	41.1	49.3	70.8	35.9	(8.7)	36.1	67.9	51.5	47.5	71.4	61.0	45.3	38.1	45.7	35.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenues
Revenues	228.6	197.1	146.8	225.2	146.1	50.5	23.4	31.2
Cost of Revenue	180.4	156.0	117.2	183.1	123.8	40.0	21.1	26.5
Gross Profit	48.2	41.1	29.6	42.1	22.3	10.5	2.3	4.7
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-
Selling General & Administrative	-	60.9	50.9	-	-
Operating Income
Operating Income	(19.6)	(22.4)	(22.5)	(68.1)	(53.5)	(24.1)	(10.4)	(11.5)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Tax & Net
Income Tax Expense	0.0	0.0	0.0	(1.5)	(0.8)	(3.6)	0.0	0.0
Net Income From Continuing Ops	(16.1)	(20.1)	(16.2)	(56.1)	(27.3)
Per Share
EPS Basic	0.55	0.50	(0.35)	(0.76)	(0.38)	(0.93)	(0.40)	(0.43)
EPS Diluted	0.52	0.50	(0.35)	(0.76)	(0.38)	(0.93)
Supplementary Data
EBITDA	(10.1)	(14.2)	(16.6)	(61.0)	(47.8)	(23.5)	(9.8)	(11.1)
EBIT	(19.6)	(22.4)	(22.5)	(68.1)	(53.5)	(24.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	15.6	-	-	-	12.3	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	0.5	1.6	1.4	3.1	0.3	2.4	2.1	2.4	2.7	2.7	2.6	2.5	1.9	1.6	1.8
General & Administrative	-	-	16.3	20.1	17.3	25.5	13.9	25.1	17.2	41.2	19.3	18.4	16.3	20.6	15.8	12.1	14.0
Depreciation & Amortization	3.1	3.6	1.1	1.8	1.7	1.5	1.3	1.6	1.6	1.8	1.8	1.8	1.7	-	-	-
Amortization of Intangibles	1.5	-	0.4	-	0.4	-	0.3	-	-	-	-	-	-	1.7	1.2	1.0	1.0
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	23.0	22.6	20.0	-	19.7	14.8	16.6
Total Operating Expenses	17.1	(79.9)	54.9	75.8	12.7	(132.5)	43.2	80.1	61.4	(7.8)	(8.2)	(7.9)	(9.3)	(8.8)	(11.0)	(8.1)

Operating Income
Operating Income	(3.0)	(6.1)	(5.6)	(5.0)	(5.7)	6.6	(7.1)	(12.1)	(9.9)	(35.6)	(7.4)	(12.2)	(12.8)	(19.7)	(10.4)	(9.7)	(13.7)	(2.4)	(7.8)	(4.2)	1.1	(0.2)	(1.5)	(0.1)	(0.0)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.9	0.2
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	5.4	1.0	(4.0)	1.2	4.1	(1.5)	1.5	0.9	5.6	0.7	7.9	(0.4)	2.4	3.4	1.2	18.1	2.7
Pre-Tax Income	2.4	(5.1)	(9.7)	(3.7)	(1.6)	5.1	(5.6)	(11.3)	(4.3)	(35.0)	0.4	(12.6)	(10.4)	(16.2)	(9.2)	8.4

Tax & Net
Income Tax Expense	0.0	(0.0)	0.0	0.0	0.0	0.0	0.0	0.1	(0.1)	(1.0)	0.1	(0.4)	(0.2)	(0.8)	0.1	0.0	0.0	-	-	-	0.1	(0.0)	(0.0)	0.2	0.0
Net Income From Continuing Ops	2.4	(5.1)	(9.7)	(3.7)	(1.6)	5.0	(5.6)	(11.3)	(4.2)	(33.9)	0.3	(12.2)	(10.2)	(15.4)	(9.2)	8.4	(11.0)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	2.2	(8.8)	57.4	(3.7)	(3.5)	(9.8)	(2.0)	(11.3)	(4.2)	(33.9)	0.3	(12.2)	(10.2)	(15.4)	(9.2)	8.4	(11.0)
Net Income Attributable To Parent	2.2	(8.8)	57.4	(3.7)	(3.5)	(9.8)	(2.0)	(11.3)	(4.2)	(33.9)	0.3	(12.2)	(10.2)	(15.4)	(9.2)	8.4
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	2.2	(8.8)	57.4	(3.7)	(3.5)	(9.8)	(2.0)	(11.3)	(4.2)	(33.9)	0.3	(12.2)	(10.2)	(15.2)	(9.2)

Per Share
EPS Basic	0.03	-	0.70	(0.05)	(0.04)	-	(0.03)	(0.15)	(0.06)	-	0.00	(0.17)	(0.14)	-	(0.13)	0.11	(0.16)	-	(0.47)	(0.16)	-	-	-	-	-
EPS Diluted	0.03	-	0.70	(0.05)	(0.04)	-	(0.03)	(0.15)	(0.06)	-	0.00	(0.17)	(0.14)	-	(0.13)	0.10	(0.16)	-
Shares Basic	85.3	-	82.5	81.3	79.9	-	78.0	77.6	75.8	-	74.1	73.2	72.0	-	71.5	71.1	70.8	-
Shares Diluted	90.2	-	82.5	81.3	79.9	-	78.0	77.6	75.8	-	81.0	73.2	72.0	-	71.5	78.5	70.8	-

Supplementary Data
EBITDA	0.1	(2.5)	(4.5)	(3.2)	(4.0)	8.1	(5.8)	(10.6)	(8.3)	(33.8)	(5.6)	(10.4)	(11.2)	-	-	-	(12.5)	-	-	(4.1)	-	-	-	-	-
EBIT	(3.0)	(6.1)	(5.6)	(5.0)	(5.7)	6.6	(7.1)	(12.1)	(9.9)	(35.6)	(7.4)	(12.2)	(12.8)	(19.7)	(10.4)	(9.7)	(13.7)	(2.4)	(7.8)